[Exam 1] Chapter 36: Management of Patients with HIV Infection and AIDS (Page 1025-1053) Flashcards

(143 cards)

1
Q

HIV-1 is transmitted by

A

body fluids containing HIV or infected CD4 lymphocytes

fluids include blood, seminal fluid, vaginal secretions, and breast milk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

HIV: Most prenatal infections occur during

A

Delivery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

HIV: And Casual Contact

A

Does not cause transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

HIV: Breaks in skin or mucosa increases

A

risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

HIV and Gerontologic Considerations: signs of HIV/AIDS can be mistaken for

A

the aches and pains of normal aging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

HIV and Gerontologic Considerations: Older adults living with HIV/AIDS also experience development of other comorbidities such as

A

cardiovascular disease, and diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

HIV and Prevention: In order to prevent the spread of HIV during intercourse, what can be done?

A

Pre-Exposure Prophylaxis (PrEP) involves taking one pill containg two HIV medications daily in order to avoid risk of sexual HIV acquisiton.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

HIV and Prevention: Women who are pregnant can take this to reduce perinatal HIV transmission

A

ART. Should also not breast-feed their infants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Preventiion for Health Care Workers

A

Hand Hygiene
PPE

Soiled Patient Care Equipment Handling

environmental Control

Textiles and Laundry

Needles and Other Sharps

Patient REsuscitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

HIV and Health Care PRovider Treatment: If exposed, what must be done?

A

Post-Exposure Prophylaxis (PEP) includes taking antiretroviral medicine as soon as possible but no more than 3 days after exposure. 2-3 drugs prescribed must be taken for 28 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

STages of HIV Disease

A

Primary Infection

HIV Asymptomatic

HIV Symptomatic

AIDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

HIV Patho: HIV is a retrovirus because

A

it carries its genetic material in the form of RNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

HIV Patho: Illness is closer when caused by

A

HIV-2, which is more common in WEstern Africa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

HIV Patho: What cna be done to screen for HIV-1?

A

Blood tests

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

HIV Patho: HIV cosnsits of a viral core contianing viral RNA surrounded by an envelope cosisiting of protruding

A

glycoproteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

HIV Patho: Virusees target cells with

A

CD4 receptors, which are expressed on surface of T Lymphocytes, Monocytes, Dendritic Cells, and Brain Microglia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

HIV Patho: Stage 0, known as acute/recent infection, attacks T Cells how?

A

USe chemokine cell receptor molecule CCR5 to entry to T cells in addition to CD4 REceptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

HIV Patho Life Cycle: (1) Attachment / Binding Stage

A

First step, GP 120 and GP 41 glycoproteins of HIV bind with CCR5 which results in fusion of HIV with CD4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

HIV Patho Life Cycle: (2) Uncoating / Fusion

A

Two strands of RNA nd three vital enzymes (reverse transcriptase, integrase and protease) emptied in here

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

HIV Patho Life Cycle:(3) DNA Syntehsis:

A

HIV changes its genetic material from RNA to DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

HIV Patho Life Cycle: (4) Integration

A

New Viral DNA enters nucleus of CD4 and bleds with DNA of CD4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

HIV Patho Life Cycle: (5) Transcription

A

When Cf4 T is acivated, DNA forms isngle stranded RNA which builds new viruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

HIV Patho Life Cycle: (6) TRanslation

A

MRNA creates chains of new proteins and enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

HIV Patho Life Cycle:(7) Cleavage

A

HIV protease enzyme cuts the polyprotein chain into the indivudual protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
HIV Patho Life Cycle:(8) Budding
New proteins and viral RNA migrate to the memrbane o fthe infacted CD4 and exit the cell
26
Hiv Patho: REsting CF4 T Cells can be stimuled to produce new particles if
something activates them, such as another infection
27
Hiv Patho: Whenevr the CD4 is activated, HIV replication and budding occur which..
can destroy the host cell. Newly formed HIV released into blood can infect over CD4 cells
28
Hiv Patho: Calculasins may have a mutation of CCR5, which may leave them
protected against HIV infection even if exposed
29
Hiv Patho: What determiens T Cells influence on HIV Acquisition?
CCR5
30
How many stages are there of HIV infection?
Five
31
Stages of HIV Infection: Period from infection with HIV to development of HIV specific antibodies is known as
primary infection or acute HIV infection and is part of stage 0
32
Stages of HIV Infection:Acute HIV infection is the inerval between
appearance of detectable HIV RNA and first detection of antibodies
33
Stages of HIV Infection:Primary or acute infection is characterized by
high levels of viral replication, widespread dissemination of HIV throughout the body, and destruction of CD4 T Cells.
34
Stages of HIV Infection:What is Viral Set Point?
The amount of virus in the body after the initial immune response subsides Results in equilivrium betwee HIV levels and the immune response.
35
Stages of HIV Infection: The higher the set point, the poorer the
prognosis
36
Stages of HIV Infection:Stage 2 occurs when
CD4 T Lymphocytes are between 200 and 499 stages.
37
Stages of HIV Infection:Stage 3 occurs when
count drops bellow 200 cells . At this point, patient is considered to have AIDS for survillence purposes.
38
Primary Infection: PArt of CDc Categorry
A
39
Primary Infection: Symptoms are
none to flulike syndrome
40
Primary Infection: WIndow PEriod is
lack of HIV antibodies
41
Primary Infection: THis is a period of
rapid viral replication and dissemination through the body
42
HIV Asymptomatic: CDC category is
A
43
HIV Asymptomatic: How many T Lymphocytes / MM^3 do youhave?
> 500
44
HIV Asymptomatic: Upon reaching the virsl set point, what happens?
Chronic asymptomatic state begins
45
HIV Asymptomatic: Body has sufficent immune response to defend against
pathogens
46
HIV Symptomatic: CDC category
B
47
HIV Symptomatic: T Cell Count is between
200-499
48
HIV Symptomatic: CD4 T Cells grdually
fall
49
HIV Symptomatic: Patient develops symptoms or conditions releated to the HIV infection, which are not classified as
Category C infections
50
HIV Symptomatic: Patients who are once treated for Category B condiiton are considered
Category B
51
AIDS: CDC category
C
52
AIDS: How many T Lymphocytes?
< 200
53
AIDS: What happens as levels drop below 100?
Immune system is significantly impaired
54
Gerontology Considerations: what percentage of populcation over 50 hasHIV?
25%
55
Gerontology Considerations: Reasons for high number of cases in this population?
Unprotected Intercourse Dont consider themselves a risk Social bias toward homosexuality MAy use IV drugs May have received HIV infected blood before 1985 REduction in immune system function
56
HIV Tests: What is used to determine if HIV infection is recent or ongoing?
Serologic Testing Algorithm (STARHS)
57
HIV Tests: What are the three types of HIV diagnostic tests?
Anti-body tests, antigen/antibody tests, and nucleic acid (rna) tests
58
HIV Tests: Antibody test detect
antibodies, not HIV itself
59
HIV Tests: Antigen and RNA Tests directly test
HIV
60
HIV Tests: Antigen/Antibody tests detect infection in blood before
Antibody tests
61
HIV Tests: Follow up testing is performed if
the intial test result is positive to ensure a correct diagnosis
62
HIV Tests: HIV Follow Up Tests Include
Antidifferentiation Tests HIV-1 Nucleic Acid Tests
63
HIV Tests: What is the EIA test?
Antibodies are detected, resulting positive results and marking the end of the window period
64
HIV Tests: What is the Western Blot?
Also detects antibodies to HIV, used to confirm EIA
65
HIV Tests: What is VIral Load?/
Measures HIV RNA in the plasma
66
HIV Tests: What is CD4/Cd8 Test
Markers found on Lymphocytes. HIV Kills CD4 cells which results in significantly impaired immune system
67
HIV Tests: What is OraQuick Test?
In-home HIV Test
68
HIV Tests: Viral Load Tests use
targeet amplification methods to quantify HIV RNA or DNA levels in teh plasma . This measures plasma HIV RNA levels
69
HIV Tests: RT-PCR is also used to detect
HIV in high-risk seronegative poeple before antibodies are measurable to confirm a positive EIA
70
HIV Tests: Virial Load is better predictor of the risk of HIV disease progression than CD4 count because
lower the viral load, the longer the time to aids diagnosis and the longer the survivial time.
71
Treatment of HIV Infection: Overreaching goal of ART is to
suppress HIV replication to a level below which drug-resistance mutations do not emerge
72
Treatment of HIV Infection: Optimal Viral Suppression is defined as
viral load persistently below the level of detection.
73
Treatment of HIV Infection: Achieving viral suppression requires use of ART with at least two or three more drugs and should occur within
12-25 weeks.
74
Treatment of HIV Infection: Different drug classes of ART target
some of the stpes in the HIV/host cycle
75
Treatment of HIV Infection: Six Classes of drugs include
Nucleoside/Nucleotide Reverse TRanscriptase Inhibitors Non-Nucleoside Reverse TRanscriptase Inhibitors Protease Inhibitors Fusion Inhibitors CCR5 Antagonist Integrase Strand TRasnfer Inhibitors
76
Treatment of HIV Infection: Adverse Effects associated with all HIV treatment regimens include
Hepatotoxicity Nephrotoxicity Osteopenia along with increased risk of cardiovascular disease
77
Treatment of HIV Infection: Many of the antiretroviral agents may cause
fat reditrubition syndrome and metabolic alterations such as dyslipidemia and insulin resistance
78
Drug REsistance: Two major components of ART resistance and they are
1. Transmission of drug-resistant HIV at the time of intial infection and 2. Selective drug resistance in patietns who are receiving non-suppressive regimens
79
Drug REsistance: Genotypic assays detect
drug-resistant mutations present in relevant viral genes while
80
Drug REsistance: Phenotypic measures
ability of a virus to grow in different concentrations of ART drugs
81
Drug REsistance: Genotypic is preferred because of
lower cost, more rapid turnaround time, the assays ability to detect mixtures of wild tpe and resistant virus and relative ease of interpreting test results
82
Immune Reconstitution Inflammatory Syndrome (IRIS) : REsults from
rapid restortion of organism specific immune response to infections that cause either the deterioration of a treated infection or new presentation
83
Immune Reconstitution Inflammatory Syndrome (IRIS) : Typically occurs when
Initial months after beginning ART and is associated with a wide spectrum of organisms , most commonly myobacteriaa.
84
Immune Reconstitution Inflammatory Syndrome (IRIS) : Characterized by
fever , respiratory, and abdominal symptoms and worsening of clinical manifestions
85
Immune Reconstitution Inflammatory Syndrome (IRIS) : Treated with
anti-inflammatory medications usch as cortisone
86
Immune Reconstitution Inflammatory Syndrome (IRIS) : Patients with HIV-TV co infection with low CD4 counts who start ART are at high risk for devlelpoing
TB_IRIS
87
HIV and Clinical Manifestations - Respiratory: What is associated with various opportunistic infections
Shortness of breath, dyspnea, cough, chest pain and fever
88
HIV and Clinical Manifestations - Respiratory and Pneumocystis Pneumonia: Caused by
P. Jorovecii and the incidience has declined substantially with widespread use of PCP Prophylaxis, which i sused to prevent PCP and ART
89
HIV and Clinical Manifestations - Respiratory and Pneumocystis Pneumonia: Most common manifestations of PCP are
subacute onset of progressive dyspnea, fever, nonproductive cough and chest discomfort that worsens within days to weeks
90
HIV and Clinical Manifestations - Respiratory and Pneumocystis Pneumonia: Is the most common
life-threatening infection
91
HIV and Clinical Manifestations - Respiratory and Pneumocystis Pneumonia: Initial symptoms may be
nonspecific and may include nonnproductive cough, fever, chills, dyspnea and chest pain
92
HIV and Clinical Manifestations - Respiratory and Pneumocystis Pneumonia: If untreated, progreses to
pulmonary impairment and respiratory failure
93
HIV and Clinical Manifestations - Respiratory and Pneumocystis Pneumonia: Treamtnet includes
TMP -SMZ or PEntamidine , Prophylactic TMP-SMZ
94
HIV and Clinical Manifestations - Respiratory and Mycobacterium Avium Complex: What is this?
Disease that is a common opportunistic infection that typically occurs in patients with CD4 T Lympho count less than 50
95
HIV and Clinical Manifestations - Respiratory and Mycobacterium Avium Complex: MAC caused by
infection with diffferent types of mycobacterium
96
HIV and Clinical Manifestations - Respiratory and Mycobacterium Avium Complex: Early symptoms may be
minimal and can precede detectable mycobacterium by severalweeks and include fever, night sweats, weight loss, fatigue, diarrhea
97
HIV and Clinical Manifestations - Respiratory and Mycobacterium Avium Complex: Confirmed diagnosis based on
compatible clinical signs and symptoms coupled with isoloation of MAC from cultures of blood, lymph node, bone marrow, and other normally sterile tissues
98
HIV and Clinical Manifestations - GI: GI Manifestations include
loss of appeite, nausea, vomiting, oral and esophagal candidiasis adn chronic diarrhea
99
HIV and Clinical Manifestations - GI: Symptoms may be realted to
direct inflammatory effect of HIV Cells on lining of the intestines
100
HIV and Clinical Manifestations - GI: For patients with AIDS, effects of diarrhea cna be devasting in terms of
profound weight loss (Octreotide acetate) , fluid and electrolyte imbalance perianal skin excoveration, weakness, and inability to perform the usual activites
101
HIV and Clinical Manifestations - GI and Candidiasis: Oranpharyngeal Candidiasis is characterized by
painless, creamy white, plque like lesions that can occur on the buccal surface
102
HIV and Clinical Manifestations - GI and Candidiasis: Lesions can be easily scraped of with
a tongue depressor or other instrument
103
HIV and Clinical Manifestations - GI and Candidiasis: Treatment with
Mycelex Troches or Nystatin, Ketoconazole
104
HIV and Clinical Manifestations - GI and HIV Wasting Syndrome: Defined as
involuntary loss of more than 10% of ones body weight while having experienced diarhea or weakness and fever for more than 30 days
105
HIV and Clinical Manifestations - GI and HIV Wasting Syndrome: Wasting refers to
loss of muscle mass although part of weight loss may also be due to part of fight
106
HIV and Clinical Manifestations - GI and HIV Wasting Syndrome: hat may contribute to this?
Anorexia, diarrhea, GI malabsorption and lack of nutriton
107
HIV and Clinical Manifestations - Oncologic Manifestations: Those with HIV / AIDS are greater risk for developing certain cancers like
Kaposi Sarcoma , Lymphoma, And Invasive Cervical CAncer
108
HIV and Clinical Manifestations - Oncologic Manifestations and Kaposi Sarcoma: Caused by
human herpevirus and affects eight times more men than women. Spreads through sexual contact
109
HIV and Clinical Manifestations - Oncologic Manifestations and Kaposi Sarcoma: Involves the
epithelial layer of blood and lymphatic vessels
110
HIV and Clinical Manifestations - Oncologic Manifestations and Kaposi Sarcoma: Exhibits a variable and aggressive course, and it may start as
cutaneous lesions but may involve multiple organ systems
111
HIV and Clinical Manifestations - Oncologic Manifestations and Kaposi Sarcoma: Lesions cause
discomfort, disfigurement, ulceration and potential for infection
112
HIV and Clinical Manifestations - Oncologic Manifestations and Kaposi Sarcoma: What cna be the first manifestation?
They can appear anywehre on the body and are usually brownish pink to deep purple.
113
HIV and Clinical Manifestations - Oncologic Manifestations and Kaposi Sarcoma: Diagnosis confirmed by
biopsy of suspected lesions. Prognosis depends on the extent of the tumor
114
HIV and Clinical Manifestations - Oncologic Manifestations and AIDS Related Lymphomas: Unclude both
Hodgkin lymphoma and non-hodgkin lymphoma. Non more common
115
HIV and Clinical Manifestations - Oncologic Manifestations and AIDS Related Lymphomas: Three times of AIDS related LYmphomas?
Diffuse Large B Cells B Cell Immunoblastic Small Noncleaved Cell Lymphoma
116
HIV and Clinical Manifestations - Oncologic Manifestations and AIDS Related Lymphomas: Symptoms include
weight loss, night sweats, and fever
117
HIV and Clinical Manifestations - Neurologic Manifesations: HIV Related brain changes have profound effects on the body including
motor function, exectuvie function, attention, visual memory, and visusoatial function
118
HIV and Clinical Manifestations - Neurologic Manifesations: Neurologic dysfunction results from
direct effects of HIV on nervous sytem tissue, opportunistic infections, primary or metastatic neoplasm.,
119
HIV and Clinical Manifestations - Neurologic Manifesations and Peripheral Neuropathy: This is the most common
Neurologic symtpom at any stage of HIV infection
120
HIV and Clinical Manifestations - Neurologic Manifesations and Peripheral Neuropathy: May be side effect of some
ART drugs and may occur in a variety of patterns.
121
HIV and Clinical Manifestations - Neurologic Manifesations and Peripheral Neuropathy: Can lead to
significant pain of feet and hands and functional impairment
122
HIV and Clinical Manifestations - Neurologic Manifesations and HIV Encephalopathy: Formerly referred to as
AIDS Dementia Complex
123
HIV and Clinical Manifestations - Neurologic Manifesations and HIV Encephalopathy: Clinical syndrome that is characterized by
progressive decline in cognitive, behavioral, and motor functions as a direct result of HIV.
124
HIV and Clinical Manifestations - Neurologic Manifesations and HIV Encephalopathy: HIV infection is thought to trigger relase of
toxins or lymphokines that result in cellular dysfunction, inflammation, or intereference with neurotransmitter function
125
HIV and Clinical Manifestations - Neurologic Manifesations and HIV Encephalopathy: Signs and Symptoms may be subtle but include
memory deficits, headache, difficulty concentrating, progressive confusion, psychomotor slowing , apathy and ataxia
126
HIV and Clinical Manifestations - Neurologic Manifesations and HIV Encephalopathy: LAter stages of signs and symptoms include
Cognitive impairment, delay in verbal responses, a vacant stare and hyperflexia
127
HIV and Clinical Manifestations - Neurologic Manifesations and HIV Encephalopathy: Diagnosing includes
Extensive CT Scan. MRI and analysis of CSF as well.
128
HIV and Clinical Manifestations - Neurologic Manifesations and HIV Encephalopathy: Probably related to
HIV infection
129
HIV and Clinical Manifestations - Neurologic Manifesations and Cytococcus NEoformans: What is this?
Fungal infection characterized by fever, headache, malaise, stiff neck, nause and mental status changes
130
HIV and Clinical Manifestations - Neurologic Manifesations and Progressive Multifocal Leukoencephalopathy: What is this?
Demyelinating CNS disorder tha taffects the oligodendroglia.
131
HIV and Clinical Manifestations - Neurologic Manifesations and Progressive Multifocal Leukoencephalopathy: Clinical manifcations include
mental confusion and rapidly progress to include blidness, aphasia, muscle weakness, paresis and death
132
HIV and Clinical Manifestations - Neurologic Manifesations and Depressive Manifestations: What substanceshave been associated with this?
Cocaine and Alcohol use and depression has been associated with less adherence with ART
133
HIV and Clinical Manifestations - Neurologic Manifesations and Integumentary Manifestations: Cutanous manifestions are associated with
HIV infection and the accompanying opportunistic iinfections and malignancies
134
HIV and Clinical Manifestations - Neurologic Manifesations and Treatment of Pneumocystis Pneumonia: Persons in stage 3 HIV should reieve
Chemoprophylaxis to prevent PCP with trimetroprim.
135
HIV and Clinical Manifestations - Neurologic Manifesations and Treatment of Pneumocystis Pneumonia: When person diagosed with PCP, What is the treatment of choice?
TMP-SMX lowering the dose if there was any abnromal renal function
136
HIV and Clinical Manifestations - Neurologic Manifesations and Treatment of Pneumocystis Pneumonia: Treatment duration lasts
21 days
137
HIV and Clinical Manifestations - Neurologic Manifesations and Treatment of Pneumocystis Pneumonia: Should be started when?
As soon as possible, preferentially within 72 hours.
138
HIV and Clinical Manifestations - Neurologic Manifesations and Treatment of Mobacterium Avium Complex: Initial treatment should consist of
2 or moer antimycobacteial drugs to prevent the delay the emergence of resistance
139
HIV and Clinical Manifestations - Neurologic Manifesations and Treatment of Mobacterium Avium Complex: Preferred first agent?
Clarithromycin but Azithromycin can be subbed
140
HIV and Clinical Manifestations - Neurologic Manifesations and Treatment of Cypotoccal Meningitis: Most commonly occurs as
subacute meningitis or meningoencephalitis with fever, malaise, and headache..
141
HIV and Clinical Manifestations - Neurologic Manifesations and Treatment of Crypotococcal Meningitis: Treatment includes
Three phasees, induction, consolidation, and maintenace.
142
Nursing Process: Care of PAtient with HIV/AIDS - Assessment: This incudes
Assess patients support system Identidy potential risk factors, IV drug abuse Immune system function Nutritonal Status Skin integrit Respiratory status fluid and electrolyte balance
143
Nursing Process: Care of PAtient with HIV/AIDS - Assessment: Nutritonal status obtained by
obtaining a dietary history and idetnifying factors that may interfere with oral intake